Why It Matters
Cliffwater LLC‘s shift into financial regulation lobbying signals serious ambitions in a rapidly changing landscape. The alternative asset manager is expanding beyond tax-focused efforts to directly shape fund fee disclosure rules—a technical but consequential issue affecting how investment products compete for capital.
Congressional legislation like the Access to Small Business Investor Capital Act could fundamentally alter fee calculation requirements, directly benefiting firms like Cliffwater. However, the regulatory environment remains contentious. While the SEC’s June 2024 court loss cleared space for legislative action, Senator Elizabeth Warren continues blocking efforts to expand private equity access to retirement accounts, citing concerns about "excessive fee structures."
Cliffwater’s strategic hiring of Invariant LLC represents a calculated escalation, replacing two smaller firms that cost $50,000 combined. Invariant brings firepower: Jennifer Rose Jacoby has deep SEC rulemaking expertise, while Noah Daniel Marine served as Legislative Director for a House Financial Services Committee member—critical access for navigating the committee with primary jurisdiction.
By the Numbers
Cliffwater LLC began federal lobbying in 2025, initially retaining Hogan Lovells US LLP ($30,000) and Duddington Global Strategies LLC ($20,000) for pass-through entity taxation.
The firm now engages Invariant LLC on financial services issues focused on fund fee disclosures. The lobbying team features experienced professionals: Jennifer Rose Jacoby brings regulatory expertise from representing Vanguard and Charles Schwab, while Noah Daniel Marine provides congressional access from his House Financial Services Committee experience.
The Agenda
Cliffwater LLC is lobbying on "fund fee disclosures" through Invariant LLC, targeting how acquired fund fees are calculated and disclosed to investors.
The focus directly addresses the Access to Small Business Investor Capital Act (H.R.2225/S.1808), bipartisan legislation excluding certain Business Development Company fees from prospectus disclosure tables. Industry advocates argue this corrects a "double-counting" problem making alternative funds appear more expensive.
This marks a significant shift from Cliffwater’s previous tax-focused lobbying. The firm joins major players including Carlyle Group and the Small Business Investor Alliance advocating for disclosure rule changes, navigating a landscape where bipartisan lawmakers support streamlining compliance while progressive Democrats maintain investor protection concerns.
Between The Lines
Congress is actively shaping fund fee disclosure regulations. The House Financial Services Committee held capital formation hearings addressing fee transparency, while the bipartisan Access to Small Business Investor Capital Act has attracted broad co-sponsorship from Reps. Brad Sherman and Bill Huizenga.
However, Democratic resistance remains substantial. Senator Elizabeth Warren has raised sustained concerns about "excessive fee structures" and insufficient investor protections, specifically targeting expansion into retirement accounts.
The legislative environment presents opportunity following the Fifth Circuit Court’s June 2024 decision striking down SEC private fund adviser rules, with the SEC declining to appeal. This regulatory vacuum makes legislative solutions more viable, creating a narrow window where bipartisan support exists for addressing specific fee disclosure issues while Democratic scrutiny focuses on investor protection rather than blocking all reform.
The Bottom Line
Cliffwater LLC is escalating its Washington presence, hiring Invariant LLC to lobby on fund fee disclosure rules—a strategic pivot from earlier tax-focused efforts.
The timing positions Cliffwater amid active congressional debate over the Access to Small Business Investor Capital Act, which would exclude certain fees from disclosure calculations. The firm joins Carlyle Group and the Small Business Investor Alliance in pushing the issue forward.
However, headwinds persist from Democratic skeptics like Senator Elizabeth Warren, who questions fee structures in private markets. The recent SEC court defeat eliminates a regulatory pathway, making legislative action Cliffwater’s primary avenue for influence.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article